CN111983244A - 一种干血斑中四种维生素的检测方法及检测试剂盒 - Google Patents
一种干血斑中四种维生素的检测方法及检测试剂盒 Download PDFInfo
- Publication number
- CN111983244A CN111983244A CN202010737975.8A CN202010737975A CN111983244A CN 111983244 A CN111983244 A CN 111983244A CN 202010737975 A CN202010737975 A CN 202010737975A CN 111983244 A CN111983244 A CN 111983244A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- quality control
- control product
- solution
- hydroxyvitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 92
- 239000008280 blood Substances 0.000 title claims abstract description 92
- 238000001514 detection method Methods 0.000 title claims abstract description 87
- 229940088594 vitamin Drugs 0.000 title claims abstract description 42
- 229930003231 vitamin Natural products 0.000 title claims abstract description 42
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 42
- 239000011782 vitamin Substances 0.000 title claims abstract description 42
- 238000003908 quality control method Methods 0.000 claims abstract description 70
- 239000000243 solution Substances 0.000 claims abstract description 59
- 239000011259 mixed solution Substances 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 238000005406 washing Methods 0.000 claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 109
- 239000000047 product Substances 0.000 claims description 73
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 47
- 239000000523 sample Substances 0.000 claims description 44
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 40
- 229940045997 vitamin a Drugs 0.000 claims description 39
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 38
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 38
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 38
- 239000011719 vitamin A Substances 0.000 claims description 38
- 235000019155 vitamin A Nutrition 0.000 claims description 38
- KJKIIUAXZGLUND-ICCVIKJNSA-N 25-hydroxyvitamin D2 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C KJKIIUAXZGLUND-ICCVIKJNSA-N 0.000 claims description 27
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical class C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 claims description 26
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 25
- 229930003427 Vitamin E Natural products 0.000 claims description 23
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 23
- 239000011709 vitamin E Substances 0.000 claims description 23
- 235000019165 vitamin E Nutrition 0.000 claims description 23
- 229940046009 vitamin E Drugs 0.000 claims description 23
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 19
- 235000019253 formic acid Nutrition 0.000 claims description 19
- 239000007789 gas Substances 0.000 claims description 16
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 claims description 14
- JWUBBDSIWDLEOM-DCHLRESJSA-N 25-Hydroxyvitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C/C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DCHLRESJSA-N 0.000 claims description 14
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 150000002266 vitamin A derivatives Chemical class 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- 230000008014 freezing Effects 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 9
- 238000000889 atomisation Methods 0.000 claims description 8
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims description 8
- 238000001819 mass spectrum Methods 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000007664 blowing Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000013062 quality control Sample Substances 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 19
- 238000012360 testing method Methods 0.000 description 11
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 description 9
- 235000021318 Calcifediol Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 239000012491 analyte Substances 0.000 description 6
- 239000000123 paper Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000011710 vitamin D Substances 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- SVWLIIFHXFGESG-UHFFFAOYSA-N formic acid;methanol Chemical compound OC.OC=O SVWLIIFHXFGESG-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- -1 hydroxy Chemical group 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010737975.8A CN111983244A (zh) | 2020-07-28 | 2020-07-28 | 一种干血斑中四种维生素的检测方法及检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010737975.8A CN111983244A (zh) | 2020-07-28 | 2020-07-28 | 一种干血斑中四种维生素的检测方法及检测试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111983244A true CN111983244A (zh) | 2020-11-24 |
Family
ID=73444654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010737975.8A Pending CN111983244A (zh) | 2020-07-28 | 2020-07-28 | 一种干血斑中四种维生素的检测方法及检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111983244A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114441674A (zh) * | 2022-01-17 | 2022-05-06 | 天津国科医工科技发展有限公司 | 维生素d的痕量检测方法及试剂盒 |
CN114527230A (zh) * | 2022-02-28 | 2022-05-24 | 上海药明奥测医疗科技有限公司 | 一种人干血斑中维生素a和维生素e浓度的检测方法 |
CN115308346A (zh) * | 2022-09-02 | 2022-11-08 | 汤臣倍健股份有限公司 | 血液中多种维生素的提取及含量检测方法 |
CN115326993A (zh) * | 2022-09-04 | 2022-11-11 | 湖南新大陆生物技术有限公司 | 适用于干血斑样本中维生素d的质谱检测试剂盒及检测方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106908554A (zh) * | 2017-03-24 | 2017-06-30 | 北京爱普益医学检验中心有限公司 | 一种干血斑中维生素d含量的检测方法 |
CN108107133A (zh) * | 2018-01-17 | 2018-06-01 | 中国医学科学院北京协和医院 | 液相色谱串联质谱测定血清中维生素a和e的方法 |
CN108802221A (zh) * | 2018-06-12 | 2018-11-13 | 杭州度安医学检验实验室有限公司 | 末梢血中维生素a和维生素e的微量检测方法 |
CN109212091A (zh) * | 2018-10-24 | 2019-01-15 | 天津国科医工科技发展有限公司 | 血清中25-羟基维生素d液相色谱串联质谱联用检测方法及试剂盒 |
CN110133135A (zh) * | 2019-05-20 | 2019-08-16 | 山东博济医药科技有限公司 | 多种脂溶性维生素的含量测定方法 |
CN110470753A (zh) * | 2019-07-24 | 2019-11-19 | 天津国科医工科技发展有限公司 | 一种干血斑中四种免疫抑制剂检测方法及检测试剂盒 |
CN110763788A (zh) * | 2018-07-26 | 2020-02-07 | 深圳华大生命科学研究院 | 一种定量检测血浆中5种脂溶性维生素的试剂盒及方法 |
-
2020
- 2020-07-28 CN CN202010737975.8A patent/CN111983244A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106908554A (zh) * | 2017-03-24 | 2017-06-30 | 北京爱普益医学检验中心有限公司 | 一种干血斑中维生素d含量的检测方法 |
CN108107133A (zh) * | 2018-01-17 | 2018-06-01 | 中国医学科学院北京协和医院 | 液相色谱串联质谱测定血清中维生素a和e的方法 |
CN108802221A (zh) * | 2018-06-12 | 2018-11-13 | 杭州度安医学检验实验室有限公司 | 末梢血中维生素a和维生素e的微量检测方法 |
CN110763788A (zh) * | 2018-07-26 | 2020-02-07 | 深圳华大生命科学研究院 | 一种定量检测血浆中5种脂溶性维生素的试剂盒及方法 |
CN109212091A (zh) * | 2018-10-24 | 2019-01-15 | 天津国科医工科技发展有限公司 | 血清中25-羟基维生素d液相色谱串联质谱联用检测方法及试剂盒 |
CN110133135A (zh) * | 2019-05-20 | 2019-08-16 | 山东博济医药科技有限公司 | 多种脂溶性维生素的含量测定方法 |
CN110470753A (zh) * | 2019-07-24 | 2019-11-19 | 天津国科医工科技发展有限公司 | 一种干血斑中四种免疫抑制剂检测方法及检测试剂盒 |
Non-Patent Citations (2)
Title |
---|
贾妍;战思恩;翟燕红;姜小梅;覃素姿;曹正;: "液相色谱串联质谱法测定血清维生素A、E含量", 标记免疫分析与临床, no. 04 * |
韩吉春;王小臣;李广林;赵雅君;骆亦奇;: "液相色谱-串联质谱法检测干血点样本中25-羟基维生素D_2和25-羟基维生素D_3", 分析化学, no. 03 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114441674A (zh) * | 2022-01-17 | 2022-05-06 | 天津国科医工科技发展有限公司 | 维生素d的痕量检测方法及试剂盒 |
CN114527230A (zh) * | 2022-02-28 | 2022-05-24 | 上海药明奥测医疗科技有限公司 | 一种人干血斑中维生素a和维生素e浓度的检测方法 |
CN115308346A (zh) * | 2022-09-02 | 2022-11-08 | 汤臣倍健股份有限公司 | 血液中多种维生素的提取及含量检测方法 |
CN115326993A (zh) * | 2022-09-04 | 2022-11-11 | 湖南新大陆生物技术有限公司 | 适用于干血斑样本中维生素d的质谱检测试剂盒及检测方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111983244A (zh) | 一种干血斑中四种维生素的检测方法及检测试剂盒 | |
TW201305561A (zh) | 藉由來自血漿分離器裝置(psd)之lc-ms/ms分析血漿中之總高半胱胺酸及甲基丙二酸 | |
CN101438148A (zh) | 利用质谱判别异构体的方法 | |
CN109975461A (zh) | 维生素d及其代谢物的质谱检测用校准品和质控品及其制备方法和应用 | |
CN109884300A (zh) | 结肠癌诊断标志物及其应用 | |
US20230282355A1 (en) | Integrated Biomarker System for Evaluating Risks of Impaired Fasting Glucose (IFG) and Type 2 Diabetes Mellitus (T2DM) | |
CN113125601B (zh) | 一种同时检测血清中4种脂溶性维生素的浓度的方法 | |
CN110174477A (zh) | 液相色谱串联质谱测定样品中游离维生素d的方法 | |
CN114935620A (zh) | 一种同时定量检测78种神经精神类药物的试剂盒 | |
CN112083111A (zh) | 一种慢性药物性肝损伤相关肝硬化非侵入性诊断标志物及其应用 | |
CN108802221A (zh) | 末梢血中维生素a和维生素e的微量检测方法 | |
CN110068644A (zh) | 高效液相色谱串联质谱测定血浆中奥氮平浓度的方法 | |
CN110850006A (zh) | 一种慢性阻塞性肺病诊断试剂及试剂盒 | |
CN114280177A (zh) | 一种脂溶性维生素a、d、e的检测方法 | |
CN111830146A (zh) | 一种干血片中25-羟基维d的lc-ms/ms高通量检测方法及试剂盒 | |
CN114994218A (zh) | 液相色谱串联质谱检测干血斑中4种脂溶性维生素的检测试剂盒及其检测方法 | |
Matern et al. | Innovative non-or minimally-invasive technologies for monitoring health and nutritional status in mothers and young children | |
CN111855832A (zh) | 一种维d及其代谢物的质谱检测用校准和质控品的制备方法 | |
CN116183746A (zh) | 一种基于检测尿液中代谢物含量评估机体衰老程度的方法及其应用 | |
CN112305124B (zh) | 一种生物标志物及其在疾病诊断中的应用 | |
CN115327129A (zh) | 一种血浆分子标志物犬尿氨酸在早期心力衰竭检测中的应用 | |
CN110824178A (zh) | 一种糖尿病早期诊断的标志物、试剂盒及其应用 | |
CN112763619A (zh) | 一种液质联用测定血浆中氟氢可的松浓度的方法 | |
CN108107133A (zh) | 液相色谱串联质谱测定血清中维生素a和e的方法 | |
CN116026971B (zh) | 一种用于人血清和血浆中全谱脂溶性维生素及其代谢物检测的试剂盒及检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Country or region after: China Address after: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant after: Tianjin Guoke Medical Technology Development Co.,Ltd. Address before: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant before: TIANJIN GUOKE YIGONG TECHNOLOGY DEVELOPMENT Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240325 Address after: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant after: Tianjin Guoke Medical Technology Development Co.,Ltd. Country or region after: China Applicant after: Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Address before: Building 4, No.16 Wujing Road, development zone, Dongli District, Tianjin Applicant before: Tianjin Guoke Medical Technology Development Co.,Ltd. Country or region before: China |